Research advances in treatment methods and drug development for rare diseases
As the incidence of rare diseases increases each year, the total number of rare disease patients worldwide is nearly 400 million. Orphan medications are drugs used to treat rare diseases. Orphan drugs, however, are rare and patients often struggle to utilize them and expensive medications during tre...
Main Authors: | Qiaoqiao Han, Hengtao Fu, Xiaoyue Chu, Ruixin Wen, Miao Zhang, Tao You, Peng Fu, Jian Qin, Tao Cui |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.971541/full |
Similar Items
-
Orphan drugs and rare diseases /
by: Pryde, David C., editor, et al.
Published: (2014) -
Drug repurposing for rare: progress and opportunities for the rare disease community
by: Anneliene Hechtelt Jonker, et al.
Published: (2024-01-01) -
Cross-national comparative study of orphan drug policies in Saudi Arabia, the United States, and the European Union
by: Bander Balkhi, et al.
Published: (2023-09-01) -
Historical and projected public spending on drugs for rare diseases in Canada between 2010 and 2025
by: Richard Lech, et al.
Published: (2022-10-01) -
Current Status and Prospect of Orphan Drugs for Rare Skin Diseases in China
by: ZHANG Shan, et al.
Published: (2023-04-01)